These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 16157919)

  • 1. Lack of beta-methylamino-l-alanine in brain from controls, AD, or Chamorros with PDC.
    Montine TJ; Li K; Perl DP; Galasko D
    Neurology; 2005 Sep; 65(5):768-9. PubMed ID: 16157919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence of beta-methylamino-l-alanine (BMAA) in ALS/PDC patients from Guam.
    Murch SJ; Cox PA; Banack SA; Steele JC; Sacks OW
    Acta Neurol Scand; 2004 Oct; 110(4):267-9. PubMed ID: 15355492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease.
    Pablo J; Banack SA; Cox PA; Johnson TE; Papapetropoulos S; Bradley WG; Buck A; Mash DC
    Acta Neurol Scand; 2009 Oct; 120(4):216-25. PubMed ID: 19254284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal models of BMAA neurotoxicity: a critical review.
    Karamyan VT; Speth RC
    Life Sci; 2008 Jan; 82(5-6):233-46. PubMed ID: 18191417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Return of the cycad hypothesis - does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health?
    Ince PG; Codd GA
    Neuropathol Appl Neurobiol; 2005 Aug; 31(4):345-53. PubMed ID: 16008818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-N-methylamino-l-alanine induces oxidative stress and glutamate release through action on system Xc(-).
    Liu X; Rush T; Zapata J; Lobner D
    Exp Neurol; 2009 Jun; 217(2):429-33. PubMed ID: 19374900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a role for naturally occurring cyanobacterial toxins in neurodegeneration? The beta-N-methylamino-L-alanine (BMAA) paradigm.
    Papapetropoulos S
    Neurochem Int; 2007 Jun; 50(7-8):998-1003. PubMed ID: 17296249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Creating a Simian Model of Guam ALS/PDC Which Reflects Chamorro Lifetime BMAA Exposures.
    Banack SA; Cox PA
    Neurotox Res; 2018 Jan; 33(1):24-32. PubMed ID: 28478528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases.
    Bradley WG; Mash DC
    Amyotroph Lateral Scler; 2009; 10 Suppl 2():7-20. PubMed ID: 19929726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain volumes in Guam dementia vs Parkinson dementia complex vs aging Chamorro adults.
    Kaye JA; Moore MM; Galasko D; Craig UK; Adonay R; Silbert LC
    Neurology; 2007 Jul; 69(2):196-9. PubMed ID: 17620553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tales of Pacific tangles: Cycad exposure and Guamanian neurodegenerative diseases.
    Friedland RP; Armon C
    Neurology; 2007 May; 68(21):1759-61. PubMed ID: 17515536
    [No Abstract]   [Full Text] [Related]  

  • 12. Retention of the cyanobacterial neurotoxin beta-N-methylamino-l-alanine in melanin and neuromelanin-containing cells--a possible link between Parkinson-dementia complex and pigmentary retinopathy.
    Karlsson O; Berg C; Brittebo EB; Lindquist NG
    Pigment Cell Melanoma Res; 2009 Feb; 22(1):120-30. PubMed ID: 19154235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam.
    Cox PA; Banack SA; Murch SJ
    Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13380-3. PubMed ID: 14612559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of dementia in Chamorros on Guam: relationship to age, gender, education, and APOE.
    Galasko D; Salmon D; Gamst A; Olichney J; Thal LJ; Silbert L; Kaye J; Brooks P; Adonay R; Craig UK; Schellenberg G; Borenstein AR
    Neurology; 2007 May; 68(21):1772-81. PubMed ID: 17515539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurodegenerative disease. Guam's deadly stalker: on the loose worldwide?
    Miller G
    Science; 2006 Jul; 313(5786):428-31. PubMed ID: 16873621
    [No Abstract]   [Full Text] [Related]  

  • 16. Cerebral uptake and protein incorporation of cyanobacterial toxin β-N-methylamino-L-alanine.
    Xie X; Basile M; Mash DC
    Neuroreport; 2013 Oct; 24(14):779-84. PubMed ID: 23979257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Amino-3-(methylamino)-propanoic acid (BMAA) in cycad flour: an unlikely cause of amyotrophic lateral sclerosis and parkinsonism-dementia of Guam.
    Duncan MW; Steele JC; Kopin IJ; Markey SP
    Neurology; 1990 May; 40(5):767-72. PubMed ID: 2330104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans.
    Chernoff N; Hill DJ; Diggs DL; Faison BD; Francis BM; Lang JR; Larue MM; Le TT; Loftin KA; Lugo JN; Schmid JE; Winnik WM
    J Toxicol Environ Health B Crit Rev; 2017; 20(4):1-47. PubMed ID: 28598725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blue-green algae or cyanobacteria in the intestinal micro-flora may produce neurotoxins such as Beta-N-Methylamino-L-Alanine (BMAA) which may be related to development of amyotrophic lateral sclerosis, Alzheimer's disease and Parkinson-Dementia-Complex in humans and Equine Motor Neuron Disease in horses.
    Brenner SR
    Med Hypotheses; 2013 Jan; 80(1):103. PubMed ID: 23146671
    [No Abstract]   [Full Text] [Related]  

  • 20. Dietary exposure to an environmental toxin triggers neurofibrillary tangles and amyloid deposits in the brain.
    Cox PA; Davis DA; Mash DC; Metcalf JS; Banack SA
    Proc Biol Sci; 2016 Jan; 283(1823):. PubMed ID: 26791617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.